GB Group Ord Shs GBGPF

Dropping

[NEWBIE65]

Did I miss something?

[SJSilver]

No just weak hands, expectations of earnings this a m and nothing to show probably scared a few...? Regardless this is long for me, I have patience..will crystallize along the way 

[LettinPoniesRun]

Low volume does contribute to the weak hands arguement....  Anyone have any input on why volume is so low on CMED vs. competitors?

[Seanigan]

This stock has been in consolidation which always leads to dwindling volume. Plus there are less pump and dumpers and penny flippers in this stock because of the high share price. The market has been waiting for financials to get a better sense of how to value the share price. Numbers should have been out this morning. A little worrisome. 

[LettinPoniesRun]

Was there a set timeline for #'s?... I would like to see them but I don't know if they are going to be as strong as they will be in March.. The problem with CMED's stock price is that it is high however debt is low. What get's overlooked is the Market Cap (only $25-270 Million Range).... Their top large competitors (APH, ACB)  are around the 700 Market cap level with Canopy

[DanielBoone733]

https://www.newcannabisventures.com/10-canadian-cannabis-lps-heat-up-ahead-of-key-legislation-introduction/ CanniMed Therapeutics (TSX: CMED) (OTC: CMMDF), up 11.6% YTD, priced its IPO at $12 in late December. After a rough start, the stock recovered initial losses, allowing the underwriters to exercise the over-allotment option and boosting the total deal to $69mm. The company, which